Evidence map›Paper›PMID 30121609›Full record

ArticleBMJ open2018

Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: protocol for a qualitative study.

Abdul Salam, Ruth Webster, Anushka Patel, Pavithra Godamunne, Arunasalam Pathmeswaran, H Asita de Silva, Anthony Rogers, Stephen Jan, Tracey-Lea Laba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdul SalamThe George Institute for Global Health, University of New South Wales, Hyderabad, India.ORCID 0000-0002-5870-7936
Ruth WebsterThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Anushka PatelThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Pavithra GodamunneDepartment of Medical Education, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
Arunasalam PathmeswaranDepartment of Public Health, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
H Asita de SilvaClinical Trials Unit, Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
Anthony RogersThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Stephen JanThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Tracey-Lea LabaMenzies Centre for Health Policy, Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia.ORCID 0000-0002-5182-9092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGlobally, the prevalence of uncontrolled hypertension is high, particularly in low- and middle-income countries. There is a critical need for strategies to improve hypertension control. The early use of a fixed low-dose combination of three antihypertensive drugs (triple pill) has the potential to significantly improve hypertension control. The METHODS AND ANALYSIS: Face-to-face semistructured in-depth interviews with a purposive sample of TRIUMPH RCT participants and healthcare professionals in Sri Lanka will be conducted. Healthcare professionals will include physicians and their staff who were involved in conducting the TRIUMPH RCT. Interviewees will be recruited sequentially until thematic saturation is achieved. Interviews will be audio recorded, transcribed verbatim and analysed in NVivo using framework analysis methods. ETHICS AND DISSEMINATION: The TRIUMPH RCT and process evaluation have received approval from the relevant Ethics Review Committee. All participants will be asked to provide written consent before participation. Findings from the study will be disseminated through publications and conference presentations. TRIAL REGISTRATION NUMBER: ACTRN12612001120864 , SLCTR/2015/020 ; Pre-results.

Indexed as

Antihypertensive AgentsHypertensionQuality ImprovementClinical ProtocolsFemaleHumansInterviews as TopicMaleQualitative ResearchRandomized Controlled Trials as TopicAntihypertensive AgentsBp lowering drugscombination therapyhypertension controlprocess evaluation

Identifiers

PMID30121609
PMCPMC6104790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.